Pages that link to "Q38254989"
Jump to navigation
Jump to search
The following pages link to Chitosan-based vaccine adjuvants: incomplete characterization complicates preclinical and clinical evaluation. (Q38254989):
Displaying 12 items.
- Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes (Q26852816) (← links)
- Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy (Q33612179) (← links)
- Immune cell impact of three differently coated lipid nanocapsules: pluronic, chitosan and polyethylene glycol (Q36427935) (← links)
- The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons (Q36857386) (← links)
- Effect of Chitosan Properties on Immunoreactivity (Q36941468) (← links)
- Chitosan and Sodium Alginate Combinations Are Alternative, Efficient, and Safe Natural Adjuvant Systems for Hepatitis B Vaccine in Mouse Model. (Q37132243) (← links)
- Evaluation of mucosal adjuvants and immunization routes for the induction of systemic and mucosal humoral immune responses in macaques (Q37320147) (← links)
- Poly-ϵ-caprolactone/chitosan nanoparticles provide strong adjuvant effect for hepatitis B antigen (Q38693411) (← links)
- Current Status and New Perspectives on Chitin and Chitosan as Functional Biopolymers (Q38992618) (← links)
- Poly-ε-caprolactone/Chitosan and Chitosan Particles: Two Recombinant Antigen Delivery Systems for Intranasal Vaccination. (Q53123215) (← links)
- How the Lack of Chitosan Characterization Precludes Implementation of the Safe-by-Design Concept (Q90643235) (← links)
- Nanoparticle or conventional adjuvants: which one improves immune response against Brucellosis? (Q92550530) (← links)